Ajoeb Baridi

Ajoeb has a proven cross-functional and international track record in both pre-launch and post-launch activities with novel compounds, working in a clinical setting, whilst successfully implementing Med Affairs strategy for Europe, US, Latin America and Asia Pacific. Therapy areas: Oncology, Haematology, Neurology, Autoimmune Disease, Dermatology, COVID19.

• European Cluster Medical Franchise Director - Oncology & Haematology/Ad-interim Global BD team – Kyowa Kirin, London
• Head of Global Medical Affairs - Neurology, Oncology & COVID19 – Senzer Pharmaceuticals, London
• European Regional Medical Advisor - Oncology & Haematology – Daiichi Sankyo, London/Munich
• MSL - Autoimmune Disease – Abbvie, London
• MSL - Oncology – Novartis, London
• BD & Licensing - Mundipharma, Cambridge, UK

• PhD - Cancer stem cell research – Clinical School of Medicine, University of Cambridge, UK
• Post-Msc Diploma - Molecular Immunology & Neural stem cell research – Lund University, Sweden
• Msc - Biomedical Sciences – Utrecht University, Netherlands, Rutgers University, New Jersey, US
• Bsc - Biomedical Sciences - Utrecht University, Netherlands